Skip to main content

Table 2 Genotype and allele frequencies of APOA1 gene polymorphisms (-75 G/A and +83 C/T) among CAD cases and healthy controls

From: Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease

 

Cases (n = 300)

Controls (n = 300)

OR (95%CI)

P

Genotype

GG

175(58.3)

161(53.7)

1.00(Reference)

 

GA

104(34.7)

100(33.3)

0.96(0.68,1.36)

0.80

AA

21(7.0)

39(13.0)

0.50(0.28,0.88)

0.02

CC

221(73.7)

230(76.7)

1.00(Reference)

 

CT

54(18.0)

39(13.0)

1.44(0.92,2.26)

0.11

TT

25(8.3)

31(10.3)

0.84(0.48,1.47)

0.54

Allele

G

454(75.7)

422(70.3)

1.00(Reference)

 

A

146(24.3)

178(29.7)

0.76(0.59,0.98)

0.04

C

496(82.7)

499(83.2)

1.00(Reference)

 

T

104(17.3)

101(16.8)

1.04(0.77,1.40)

0.82

  1. APOA1, apolipoprotein A1; CAD, coronary artery disease; OR, odds ratio; CI, confidence interval